We are live on ! Find out more
SONM icon

DNA X Inc
SONM

12 hedge funds and large institutions have $346K invested in DNA X Inc in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

146% more capital inflows, than outflows

Capital inflows: $166K | Capital outflows: $67.2K

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0.64% more ownership

Funds ownership: 2.65% → 3.28% (+0.64%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

8% less funds holding

Funds holding: 13 → 12 (-1)

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$63.7K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$46.6K
3
Virtu Financial
Virtu Financial
New York
+$27.8K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$7.9K
5
StoneX Group
StoneX Group
New York
+$7.23K

Top Sellers

Rank Fund Capital Flow
1
E
Ergoteles
New York
-$21K
2
Renaissance Technologies
Renaissance Technologies
New York
-$21K
3
Two Sigma Securities
Two Sigma Securities
New York
-$17K
4
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$4.63K
5
Citigroup
Citigroup
New York
-$2.71K

SONM Hedge Fund Activity: Q2 2022 in Review

12 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q2 2022, worth a combined $346K — down 20% from $435K a quarter earlier.

Fund positioning in SONM was balanced in Q2 2022: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 2 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $63.7K. The largest seller was Ergoteles, exiting entirely with an estimated $21K sold.

  • 12 institutional investors held DNA X Inc (SONM) as of Q2 2022, down from 13 in Q1 2022.
  • Funds reported $346K of DNA X Inc stock for Q2 2022, down 20% quarter-over-quarter.
  • 4 funds opened new DNA X Inc positions in Q2 2022 and 4 closed out, a net change of 0 holders.
  • The largest DNA X Inc buyer in Q2 2022 was Millennium Management, an estimated $63.7K added.
  • The largest DNA X Inc seller in Q2 2022 was Ergoteles, an estimated $21K sold.

Based on aggregated 13F filings for Q2 2022.